L’institut Pasteur prépare-t-il un vaccin qui protège le cerveau ?

Oct 27, 2021

Roselyne Dubois answers your questions on BFMTV.

Listen to the full show on bfmtv.com.

Read next article ...

Lenti-COVID, an effective and innovative strategy for a Covid-19 intranasal vaccine

A clinical phase still needs to be initiated to confirm the innocuousness and effectiveness of this approach in humans, but as of now, the TheraVectys intranasal vaccine is attracting growing interest.

Read previous article ...

Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice

Results of the joint Pasteur-TheraVectys laboratory's work on their Covid-19 vaccine candidate based on a lentiviral vector.